May 2013

24 May 2013
Marc Le Bozec, who has been a major stakeholder in industrial and academic biotechnologies in France for more than 15 years joins CYTOO as Chief Executive Officer. For several years, he worked as a consultant in organization (Bossard Consultants) and in strategy (Arthur D. Little). He founded BioProtein Technologies and managed it for 8 years. He then joined Alfact Innovation as Chief Operating Officer, and contributed to the launch of a clinical trial for liver diseases. He then joined Cellectis, and made it grow from a promising start-up to a European leader in many fields. He was Chief...